Charles Bosshardt in Fort Oglethorpe, Georgia

Medical School: Mercer University School Of Medicine
Graduation Year: 2011
The Primary Medical Specialty for Charles Bosshardt is listed as: Gastroenterology
Approximate Years of Experience: 13
PAC (PECOS ID)#: 0143467969
NPI #: 1013215078
NPI Created On: 03/01/2011
NPI Last Updated Listed as: 04/05/2023
Primary Taxonomy Code: 207RG0100X
License Number:
77562
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Alliant Health Plans
• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope
3. Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope
4. Insertion of guide wire with dilation of esophagus using an endoscope
5. Diagnostic examination of large bowel using an endoscope
6. Biopsy of large bowel using an endoscope
7. Biopsy of large bowel using an endoscope
8. Removal of polyps or growths of large bowel using an endoscope
9. Removal of polyps or growths of large bowel using an endoscope
10. Ferritin (blood protein) level
11. Complete blood cell count (red cells, white blood cell, platelets), automated test
12. Pathology examination of tissue using a microscope, intermediate complexity
13. New patient office or other outpatient visit, typically 30 minutes
14. New patient office or other outpatient visit, typically 45 minutes
15. Established patient office or other outpatient visit, typically 5 minutes
16. Established patient office or other outpatient visit, typically 15 minutes
17. Established patient office or other outpatient, visit typically 25 minutes
18. Subsequent hospital inpatient care, typically 35 minutes per day
19. Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r